Thyroid cancer (TC) is the most common endocrine malignancy, with an increased global
incidence in recent decades, despite a substantially unchanged survival. While TC has an …

Thyroid cancer is the most common endocrine malignancy, affecting nearly 600,000 new
patients worldwide. Treatment with the BRAF inhibitor sorafenib partially prolongs …

Aim The aim of this study was to assess the feasibility of targeted therapy of thyroid
carcinoma, first exploring potential targets BRAF, EGFR and CD44v6 in patient material …

Follicular thyroid carcinoma (FTC) is the second most common type of thyroid cancer,
presenting unique diagnostic and therapeutic challenges. This review provides a …

Objective Reminiscence therapy (RT) ameliorates psychological problems and quality of life
in cancer patients. However, no study reports its effect on older papillary thyroid carcinoma …

Objective To explore the diagnostic value of contrast-enhanced ultrasound (CEUS) of
qualitative and quantitative parameters for differentiating differentiated thyroid cancers from …

This study aimed to establish and validate prognostic nomogram models for patients who
underwent 131I therapy for thyroid cancer with distant metastases. The cohort was divided …

Purpose The incidence of thyroid cancer is growing fast and surgery is the most significant
treatment of it. For patients with unilateral cN0 papillary thyroid cancer whether to dissect …

Objective: To determine the sensitivity of ACR-TIRADS scoring by comparing its results with
those obtained on biopsy of respective specimens. Method: This prospective study including …

Abstract Background/Objectives: Pediatric populations with well-differentiated thyroid cancer
typically have favorable prognoses. However, the role of radioactive iodine (RAI) ablation in …